Purpose
The emergence of carbapenem-resistant
Acinetobacter baumannii
(CRAB) poses great difficulties in clinical treatment, and has been listed by the World Health Organization as a class of pathogens in urgent need of new antibiotic development. In our previous report, the novel antimicrobial peptide Cec4 showed great potential in decreasing the clinical CRAB biofilm, but its mechanism of action is still illusive. Therefore, in order to evaluate the clinical therapeutic potential of Cec4, it is necessary to explore the mechanism of how Cec4 decreases mature biofilms.
Methods
Key genes involved in the removal of CRAB biofilms by Cec4 were analyzed using transcriptomics. Based on the results of the bioinformatics analysis, the CRISPR-Cas9 method was used to construct the deletion strain of the key gene. The pYMAb2 plasmid was used for the complementation strain construction. Finally, the roles of key genes in biofilm removal by Cec4 were determined by crystal violet staining, podocyte staining, laser confocal imaging, and MBC and MBEC
50
.
Results
Combined with transcriptome analysis, we hypothesized that
OmpH
is a key gene involved in the removal of CRAB biofilms by Cec4. Deletion of the
OmpH
gene did not affect
A. baumannii
growth, but decreased
A. baumannii
capsule thickness, increasing biofilm production, and made biofilm-state
A. baumannii
more sensitive to Cec4.
Conclusion
Cec4 decreases biofilms formed by CRAB targeting
OmpH
. Deletion of the
OmpH
gene results in an increase in biofilms and greater sensitivity to Cec4, which enhances the removal of
A. baumannii
biofilms by Cec4.